Genmab A/SGMABNASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+4.7%/yr
vs +44.2%/yr prior
5Y CAGR
+6.5%/yr
Consistent
Acceleration
-39.5pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.43B | -13.1% |
| 2024 | $9.70B | +63.1% |
| 2023 | $5.95B | -19.0% |
| 2022 | $7.35B | +75.7% |
| 2021 | $4.18B | -32.1% |
| 2020 | $6.16B | +105.0% |
| 2019 | $3.00B | +76.8% |
| 2018 | $1.70B | +14.2% |
| 2017 | $1.49B | +27.0% |
| 2016 | $1.17B | - |